A peek behind the paper – Thomas Nelson on the clinical response to pazopanib in a patient with ELST not associated with von Hippel–Lindau syndrome

Take a look behind the scenes of a recent Case Report published in the journal CNS Oncology entitled, 'Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel–Lindau syndrome'. In this peek behind the paper series, we ask first author of the study, Thomas Nelson (Cedars–Sinai Medical Center, CA, USA) about the clinical presentations of endolymphatic sac tutors (ELSTs) not associated with von Hippel–Lindau (vHL) syndrome. Thomas also discusses the current treatment options that are available for ELSTs and what further research is needed to verify the use of pazopanib.  Why did you select this case...